These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16546667)

  • 1. Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.
    Kraus S; Naor Z; Seger R
    Cancer Lett; 2006 Mar; 234(2):109-23. PubMed ID: 16546667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
    Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
    J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor.
    Maudsley S; Davidson L; Pawson AJ; Chan R; López de Maturana R; Millar RP
    Cancer Res; 2004 Oct; 64(20):7533-44. PubMed ID: 15492280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues.
    Cheung LW; Wong AS
    FEBS J; 2008 Nov; 275(22):5479-95. PubMed ID: 18959738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
    Naor Z
    Front Neuroendocrinol; 2009 Jan; 30(1):10-29. PubMed ID: 18708085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview.
    So WK; Cheng JC; Poon SL; Leung PC
    FEBS J; 2008 Nov; 275(22):5496-511. PubMed ID: 18959739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated GnRH receptor expression plus GnRH agonist treatment inhibits the growth of a subset of papillomavirus 18-immortalized human prostate cells.
    Morgan K; Stavrou E; Leighton SP; Miller N; Sellar R; Millar RP
    Prostate; 2011 Jun; 71(9):915-28. PubMed ID: 21541969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes.
    Hapgood JP; Sadie H; van Biljon W; Ronacher K
    J Neuroendocrinol; 2005 Oct; 17(10):619-38. PubMed ID: 16159375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.
    Montagnani Marelli M; Moretti RM; Mai S; Procacci P; Limonta P
    Int J Oncol; 2007 Jan; 30(1):261-71. PubMed ID: 17143537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH receptor and androgen receptor status and outcome of advanced prostate carcinomas.
    Szabó J; Bartók K; Krenács T; Szepesváry Z; Szende B
    Anticancer Res; 2009 Feb; 29(2):681-4. PubMed ID: 19331222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes.
    Rothman MS; Wierman ME
    Curr Opin Endocrinol Diabetes Obes; 2007 Aug; 14(4):306-10. PubMed ID: 17940457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induction by quinazoline-derived alpha1-blockers in prostate cancer cells: biomolecular implications and clinical relevance.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2007; 11(1):59-64. PubMed ID: 17405349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leuprolide and cetrorelix on cell growth, apoptosis, and GnRH receptor expression in primary cell cultures from human prostate carcinoma.
    Castellón E; Clementi M; Hitschfeld C; Sánchez C; Benítez D; Sáenz L; Contreras H; Huidobro C
    Cancer Invest; 2006; 24(3):261-8. PubMed ID: 16809153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP
    Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.